Roivant Long Term Debt vs Total Stockholder Equity Analysis

ROIV Stock

USD 11.39 0.15 1.33%

Roivant Sciences financial indicator trend analysis is much more than just breaking down Roivant Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Roivant Sciences is a good investment. Please check the relationship between Roivant Sciences Long Term Debt and its Total Stockholder Equity accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roivant Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

Long Term Debt vs Total Stockholder Equity

Long Term Debt vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Roivant Sciences Long Term Debt account and Total Stockholder Equity. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Roivant Sciences' Long Term Debt and Total Stockholder Equity is 0.54. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Roivant Sciences, assuming nothing else is changed. The correlation between historical values of Roivant Sciences' Long Term Debt and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Roivant Sciences are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Long Term Debt i.e., Roivant Sciences' Long Term Debt and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.54

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Long Term Debt

Long-term debt is a debt that Roivant Sciences has held for over one year. Long-term debt appears on Roivant Sciences balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Roivant Sciences balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from Roivant Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Roivant Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roivant Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.At this time, Roivant Sciences' Tax Provision is fairly stable compared to the past year. Enterprise Value is likely to climb to about 3.8 B in 2024, whereas Discontinued Operations is likely to drop slightly above 97.9 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	46.3M	48.2M	55.4M	40.6M
Total Revenue	55.3M	61.3M	70.5M	46.3M

Gross Profit Total Revenue

Roivant Sciences fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Property Plant Equipment
Total Assets		0.77	-0.79	0.1	0.99	-0.94	0.87	0.99	0.63	-0.84	-0.34	0.86	0.98	0.85	0.56	0.64	0.98	0.63	0.72	0.76	-0.97	0.8	0.63	0.98	0.4	0.85
Short Long Term Debt Total	0.77		-0.84	0.63	0.68	-0.8	0.36	0.86	0.86	-0.37	-0.73	0.95	0.65	0.98	0.91	0.38	0.66	0.81	0.93	1.0	-0.64	0.98	0.97	0.65	0.74	0.48
Other Current Liab	-0.79	-0.84		-0.27	-0.76	0.73	-0.53	-0.83	-0.91	0.45	0.62	-0.79	-0.73	-0.82	-0.6	-0.64	-0.73	-0.9	-0.78	-0.86	0.73	-0.82	-0.74	-0.72	-0.77	-0.59
Total Current Liabilities	0.1	0.63	-0.27		-0.06	-0.28	-0.38	0.21	0.59	0.38	-0.77	0.51	-0.08	0.58	0.87	-0.38	-0.08	0.53	0.56	0.63	0.1	0.6	0.8	-0.07	0.7	-0.17
Total Stockholder Equity	0.99	0.68	-0.76	-0.06		-0.9	0.92	0.96	0.54	-0.9	-0.23	0.79	1.0	0.77	0.41	0.69	1.0	0.54	0.66	0.67	-0.99	0.72	0.51	0.99	0.29	0.86
Other Liab	-0.94	-0.8	0.73	-0.28	-0.9		-0.74	-0.94	-0.69	0.7	0.55	-0.91	-0.89	-0.88	-0.66	-0.36	-0.9	-0.64	-0.8	-0.77	0.87	-0.86	-0.7	-0.9	-0.49	-0.69
Net Tangible Assets	0.87	0.36	-0.53	-0.38	0.92	-0.74		0.78	0.26	-0.96	0.1	0.5	0.94	0.48	0.09	0.71	0.94	0.3	0.32	0.34	-0.94	0.4	0.16	0.94	0.0	0.9
Property Plant And Equipment Net	0.99	0.86	-0.83	0.21	0.96	-0.94	0.78		0.69	-0.78	-0.44	0.92	0.95	0.91	0.65	0.62	0.95	0.68	0.81	0.85	-0.94	0.87	0.73	0.94	0.47	0.79
Current Deferred Revenue	0.63	0.86	-0.91	0.59	0.54	-0.69	0.26	0.69		-0.14	-0.84	0.77	0.52	0.82	0.78	0.3	0.52	0.98	0.77	0.87	-0.51	0.83	0.85	0.52	0.96	0.4
Net Debt	-0.84	-0.37	0.45	0.38	-0.9	0.7	-0.96	-0.78	-0.14		-0.16	-0.52	-0.91	-0.48	-0.1	-0.72	-0.91	-0.16	-0.34	-0.34	0.92	-0.4	-0.16	-0.91	0.14	-0.86
Retained Earnings	-0.34	-0.73	0.62	-0.77	-0.23	0.55	0.1	-0.44	-0.84	-0.16		-0.7	-0.19	-0.69	-0.78	0.18	-0.2	-0.74	-0.77	-0.73	0.16	-0.76	-0.81	-0.19	-0.88	0.05
Accounts Payable	0.86	0.95	-0.79	0.51	0.79	-0.91	0.5	0.92	0.77	-0.52	-0.7		0.76	0.98	0.83	0.33	0.76	0.7	0.96	0.94	-0.73	0.99	0.9	0.75	0.62	0.51
Cash	0.98	0.65	-0.73	-0.08	1.0	-0.89	0.94	0.95	0.52	-0.91	-0.19	0.76		0.74	0.4	0.7	1.0	0.53	0.61	0.64	-1.0	0.68	0.48	1.0	0.27	0.9
Non Current Assets Total	0.85	0.98	-0.82	0.58	0.77	-0.88	0.48	0.91	0.82	-0.48	-0.69	0.98	0.74		0.89	0.38	0.75	0.78	0.93	0.98	-0.73	0.98	0.94	0.74	0.68	0.56
Non Currrent Assets Other	0.56	0.91	-0.6	0.87	0.41	-0.66	0.09	0.65	0.78	-0.1	-0.78	0.83	0.4	0.89		0.03	0.4	0.73	0.8	0.9	-0.38	0.87	0.97	0.4	0.75	0.29
Other Assets	0.64	0.38	-0.64	-0.38	0.69	-0.36	0.71	0.62	0.3	-0.72	0.18	0.33	0.7	0.38	0.03		0.7	0.39	0.24	0.39	-0.74	0.3	0.18	0.68	0.09	0.78
Cash And Short Term Investments	0.98	0.66	-0.73	-0.08	1.0	-0.9	0.94	0.95	0.52	-0.91	-0.2	0.76	1.0	0.75	0.4	0.7		0.53	0.61	0.64	-1.0	0.69	0.49	1.0	0.27	0.89
Net Receivables	0.63	0.81	-0.9	0.53	0.54	-0.64	0.3	0.68	0.98	-0.16	-0.74	0.7	0.53	0.78	0.73	0.39	0.53		0.68	0.83	-0.52	0.76	0.8	0.53	0.94	0.48
Common Stock Shares Outstanding	0.72	0.93	-0.78	0.56	0.66	-0.8	0.32	0.81	0.77	-0.34	-0.77	0.96	0.61	0.93	0.8	0.24	0.61	0.68		0.93	-0.58	0.98	0.9	0.6	0.66	0.29
Non Current Liabilities Total	0.76	1.0	-0.86	0.63	0.67	-0.77	0.34	0.85	0.87	-0.34	-0.73	0.94	0.64	0.98	0.9	0.39	0.64	0.83	0.93		-0.63	0.97	0.97	0.63	0.77	0.47
Other Current Assets	-0.97	-0.64	0.73	0.1	-0.99	0.87	-0.94	-0.94	-0.51	0.92	0.16	-0.73	-1.0	-0.73	-0.38	-0.74	-1.0	-0.52	-0.58	-0.63		-0.66	-0.46	-0.99	-0.25	-0.92
Other Stockholder Equity	0.8	0.98	-0.82	0.6	0.72	-0.86	0.4	0.87	0.83	-0.4	-0.76	0.99	0.68	0.98	0.87	0.3	0.69	0.76	0.98	0.97	-0.66		0.95	0.68	0.71	0.44
Total Liab	0.63	0.97	-0.74	0.8	0.51	-0.7	0.16	0.73	0.85	-0.16	-0.81	0.9	0.48	0.94	0.97	0.18	0.49	0.8	0.9	0.97	-0.46	0.95		0.48	0.8	0.31
Total Current Assets	0.98	0.65	-0.72	-0.07	0.99	-0.9	0.94	0.94	0.52	-0.91	-0.19	0.75	1.0	0.74	0.4	0.68	1.0	0.53	0.6	0.63	-0.99	0.68	0.48		0.27	0.9
Short Term Debt	0.4	0.74	-0.77	0.7	0.29	-0.49	0.0	0.47	0.96	0.14	-0.88	0.62	0.27	0.68	0.75	0.09	0.27	0.94	0.66	0.77	-0.25	0.71	0.8	0.27		0.17
Property Plant Equipment	0.85	0.48	-0.59	-0.17	0.86	-0.69	0.9	0.79	0.4	-0.86	0.05	0.51	0.9	0.56	0.29	0.78	0.89	0.48	0.29	0.47	-0.92	0.44	0.31	0.9	0.17

Click cells to compare fundamentals

Roivant Sciences Account Relationship Matchups

Roivant Sciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.5B	2.6B	2.6B	2.4B	2.7B	2.5B
Short Long Term Debt Total	180.9M	245.0M	283.9M	481.4M	553.6M	293.6M
Other Current Liab	70.4M	180.2M	128.2M	15.1M	13.6M	12.9M
Total Current Liabilities	92.1M	219.0M	184.4M	272.4M	313.3M	215.4M
Total Stockholder Equity	2.0B	1.8B	2.0B	1.6B	1.8B	1.8B
Other Liab	103.2M	76.1M	66.8M	80.6M	72.5M	71.0M
Net Tangible Assets	2.0B	1.8B	1.7B	1.0B	1.2B	1.6B
Property Plant And Equipment Net	73.9M	77.0M	86.9M	92.3M	106.2M	75.1M
Current Deferred Revenue	3.6M	5.9M	10.1M	167.1M	192.2M	201.8M
Net Debt	(2.0B)	(1.8B)	(1.8B)	(1.2B)	(1.1B)	(1.1B)
Retained Earnings	(1.1B)	(1.9B)	(2.8B)	(3.8B)	(3.4B)	(3.6B)
Accounts Payable	10.3M	20.6M	34.6M	37.8M	43.5M	24.1M
Cash	2.2B	2.1B	2.1B	1.7B	1.9B	1.9B
Non Current Assets Total	257.8M	402.7M	438.6M	591.0M	679.7M	416.3M
Non Currrent Assets Other	6.7M	36.1M	25.8M	49.5M	56.9M	30.7M
Other Assets	90.4M	36.1M	25.8M	49.5M	44.5M	35.9M
Cash And Short Term Investments	2.2B	2.1B	2.1B	1.7B	1.9B	1.9B
Net Receivables	15.3M	13.8M	6.7M	32.7M	37.6M	39.5M
Liabilities And Stockholders Equity	2.5B	2.6B	2.6B	2.4B	2.7B	2.5B
Non Current Liabilities Total	276.2M	308.7M	339.3M	509.6M	586.0M	368.1M
Other Current Assets	18.5M	54.3M	82.2M	121.8M	109.6M	96.3M
Other Stockholder Equity	3.1B	3.7B	4.8B	5.4B	6.2B	4.4B
Total Liab	368.4M	527.7M	546.2M	782.0M	899.3M	588.4M
Total Current Assets	2.2B	2.2B	2.1B	1.8B	2.1B	2.1B
Accumulated Other Comprehensive Income	(2.3M)	1.4M	(946K)	(2.6M)	(2.4M)	(2.2M)
Short Term Debt	7.8M	12.3M	11.4M	52.4M	60.3M	63.3M
Property Plant Equipment	73.9M	77.0M	25.9M	39.1M	44.9M	50.0M

Roivant Sciences Investors Sentiment

The influence of Roivant Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Roivant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Roivant Sciences' public news can be used to forecast risks associated with an investment in Roivant. The trend in average sentiment can be used to explain how an investor holding Roivant can time the market purely based on public headlines and social activities around Roivant Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Roivant Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Roivant Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Roivant Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Roivant Sciences.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Roivant Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Roivant Sciences' short interest history, or implied volatility extrapolated from Roivant Sciences options trading.

Currently Active Assets on Macroaxis

LAAC	Lithium Americas Corp
F	Ford Motor
CHPT	ChargePoint Holdings
AXL	American Axle Manufacturing
ICLN	iShares Global Clean

When determining whether Roivant Sciences is a strong investment it is important to analyze Roivant Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Roivant Sciences' future performance. For an informed investment choice regarding Roivant Stock, refer to the following important reports:

How To Invest In Roivant

Details

Is Roivant Stock a good investment?

Details

What is Roivant Sciences' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roivant Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Roivant Stock analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.

	Equity Valuation Check real value of public entities based on technical and fundamental data
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Roivant Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Roivant Sciences. If investors know Roivant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Roivant Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

5.27

Revenue Per Share

0.16

Quarterly Revenue Growth

1.178

Return On Assets

(0.14)

Return On Equity

1.058

The market value of Roivant Sciences is measured differently than its book value, which is the value of Roivant that is recorded on the company's balance sheet. Investors also form their own opinion of Roivant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Roivant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Roivant Sciences' market value can be influenced by many factors that don't directly affect Roivant Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Roivant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Roivant Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Roivant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Roivant Long Term Debt vs Total Stockholder Equity Analysis

Long Term Debt vs Total Stockholder Equity

Long Term Debt vs Total Stockholder Equity Correlation Analysis

Correlation Coefficient

Long Term Debt

Total Stockholder Equity

Roivant Sciences fundamental ratios Correlations

Roivant Sciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Roivant Sciences fundamental ratios Accounts

Roivant Sciences Investors Sentiment

Currently Active Assets on Macroaxis

Complementary Tools for Roivant Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Cash	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments

Other Current Assets	- 1.0	Cash And Short Term Investments
Other Current Assets	- 1.0	Cash
Total Current Assets	- 0.99	Other Current Assets
Other Current Assets	- 0.99	Total Stockholder Equity
Other Current Assets	- 0.97	Total Assets
Net Debt	- 0.96	Net Tangible Assets